Gandeeva’s mission is to identify key druggable transient protein interactions using advanced AI approaches, visualize them with atomic resolution cryo-EM, and design precise, first-in-class molecular glues that bind specifically at these protein interfaces. This strategy allows us to discover potent, effective drugs against previously inaccessible targets
Gandeeva’s technology includes three proprietary platform modules working together to shorten the timeline for drug discovery. Our approach enables us to tackle a wide spectrum of therapeutic targets ranging from protein-protein complexes and nucleic acid-protein complexes to membrane proteins.
At Gandeeva Therapeutics, we are revolutionizing the drug discovery paradigm by applying recent ground-breaking advances in computational predictions, machine learning and cryo-EM imaging to develop precision medicines for our most challenging diseases. By combining structural biology, imaging, and computational tools, Gandeeva scientists are working to influence how proteins interact by engineering therapeutic interventions at key protein interfaces.
